Vapotherm, Inc. (VAPO): Price and Financial Metrics
GET POWR RATINGS... FREE!
VAPO POWR Grades
- VAPO scores best on the Value dimension, with a Value rank ahead of 59.05% of US stocks.
- VAPO's strongest trending metric is Stability; it's been moving up over the last 179 days.
- VAPO's current lowest rank is in the Quality metric (where it is better than 3.46% of US stocks).
VAPO Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for VAPO is -6.46 -- better than only 2.37% of US stocks.
- In terms of volatility of its share price, VAPO is more volatile than 99.31% of stocks we're observing.
- VAPOTHERM INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -285.09%, greater than the shareholder yield of only 2.04% of stocks in our set.
- Stocks that are quantitatively similar to VAPO, based on their financial statements, market capitalization, and price volatility, are TWOU, PRCH, MAPS, SANW, and TRUE.
- VAPO's SEC filings can be seen here. And to visit VAPOTHERM INC's official web site, go to www.vapotherm.com.
VAPO Valuation Summary
- VAPO's price/sales ratio is 0.3; this is 85% lower than that of the median Healthcare stock.
- VAPO's price/sales ratio has moved down 6.2 over the prior 49 months.
Below are key valuation metrics over time for VAPO.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| VAPO | 2022-11-25 | 0.3 | -1.8 | -0.2 | -0.9 |
| VAPO | 2022-11-23 | 0.2 | -1.4 | -0.1 | -0.8 |
| VAPO | 2022-11-22 | 0.2 | -1.3 | -0.1 | -0.8 |
| VAPO | 2022-11-21 | 0.2 | -1.2 | -0.1 | -0.8 |
| VAPO | 2022-11-18 | 0.2 | -1.3 | -0.1 | -0.8 |
| VAPO | 2022-11-17 | 0.2 | -1.2 | -0.1 | -0.8 |
VAPO's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- VAPO has a Quality Grade of F, ranking ahead of 3.49% of graded US stocks.
- VAPO's asset turnover comes in at 0.702 -- ranking 53rd of 186 Medical Equipment stocks.
- 500 - Internal server error
The table below shows VAPO's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-09-30 | 0.702 | 0.501 | -0.633 |
| 2021-06-30 | 0.636 | 0.505 | -0.633 |
| 2021-03-31 | 0.680 | 0.511 | -0.536 |
| 2020-12-31 | 0.688 | 0.501 | -0.623 |
| 2020-09-30 | 0.624 | 0.493 | -0.583 |
| 2020-06-30 | 0.572 | 0.480 | -0.610 |
VAPO Stock Price Chart Interactive Chart >
VAPO Price/Volume Stats
| Current price | $1.62 | 52-week high | $24.23 |
| Prev. close | $1.35 | 52-week low | $0.46 |
| Day low | $1.23 | Volume | 2,319,300 |
| Day high | $1.65 | Avg. volume | 352,236 |
| 50-day MA | $1.21 | Dividend yield | N/A |
| 200-day MA | $4.45 | Market Cap | 43.26M |
Vapotherm, Inc. (VAPO) Company Bio
Vapotherm Inc. Vapotherm, Inc. is a global medical technology company. The Company is focused on the development and commercialization of its high velocity nasal insufflations (Hi-VNI) technology products that are used to treat patients suffering from respiratory distress. Its Hi-VNI technology delivers noninvasive ventilatory support by providing heated, humidified and oxygenated air at a high velocity to patients through a comfortable small-bore nasal interface. Its Precision Flow systems uses its Hi-VNI technology. It offers three versions of its Precision Flow systems: Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. Its Precision Flow systems include a capital unit, a single-use disposable and a nasal interface. Its Precision Flow versions are integrated systems that provide precise user control of temperature, air flow and percentage oxygen through a one-button interface.
Latest VAPO News From Around the Web
Below are the latest news stories about VAPOTHERM INC that investors may wish to consider to help them evaluate VAPO as an investment opportunity.
Vapotherm (VAPO) Receives a Hold from BTIGIn a report released today, Marie Thibault from BTIG reiterated a Hold rating on Vapotherm (VAPO - Research Report). The company's shares closed yesterday at $0.48.According to TipRanks, Thibault is a 4-star analyst with an average return of 4.1% and a 34.66% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Viewray, Masimo, and Atricure.Vapotherm has an analyst consensus of Moderate Sell, with a price target consensus of $1.00.See today’s best-performing stocks on TipRanks >>Based on Vapotherm's latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $13.55 million and a GAAP net loss of $26.2 million. |
Analysts Have Conflicting Sentiments on These Healthcare Companies: Agilent (A), Vapotherm (VAPO) and Olema Pharmaceuticals (OLMA)Analysts have been eager to weigh in on the Healthcare sector with new ratings on Agilent (A – Research Report), Vapotherm (VAPO – Research Report) and Olema Pharmaceuticals (OLMA – Research Report). Agilent (A) Jefferies analyst Brandon Couillard maintained a Buy rating on Agilent today and set a price target of $168.00. The company's shares closed last Monday at $145.14. |
Vapotherm Announces Amendment to Debt AgreementEXETER, N.H., November 22, 2022--Vapotherm, Inc. (NYSE: VAPO), ("Vapotherm" or the "Company"), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering from respiratory distress, today announced that, on November 21, 2022, the Company entered into Amendment No. 3 to its Loan and Security Agreement (the "Third Amendment," with SLR Investment Corp. ("SLR" |
BTIG Keeps Their Hold Rating on Vapotherm (VAPO)BTIG analyst Marie Thibault maintained a Hold rating on Vapotherm (VAPO - Research Report) today. The company's shares opened today at $1.70.According to TipRanks, Thibault is a 4-star analyst with an average return of 3.8% and a 31.97% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Masimo, Viewray, and Irhythm Technologies.The word on The Street in general, suggests a Hold analyst consensus rating for Vapotherm with a $2.00 average price target.See today’s best-performing stocks on TipRanks >>The company has a one-year high of $25.80 and a one-year low of $0.96. Currently, Vapotherm has an average volume of 165.8K. |
Why Vapotherm Shares Are Plunging Today?Vapotherm Inc (NASDAQ: VAPO) shares plunged almost 40% after the company reported disappointing Q3 FY22 earnings. Total revenue was $13.5 million, down 65% Y/Y and missing the consensus estimate of $16.54 million. Vapotherm reported a wider EPS loss of $(0.98) compared to $(0.52) a year ago and missing the Wall Street estimate of $(0.78). The company is evaluating various capital-raising options while it continues to execute its path-to-profitability initiative, which includes converting $20 mil |
VAPO Price Returns
| 1-mo | 28.57% |
| 3-mo | -17.35% |
| 6-mo | -46.00% |
| 1-year | -92.74% |
| 3-year | -84.70% |
| 5-year | N/A |
| YTD | -92.18% |
| 2021 | -22.90% |
| 2020 | 120.89% |
| 2019 | -39.05% |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...